Review and analysis of misdiagnosis of Sjögren's syndrome with salivary gland mass

doi:10.19438/j.cjoms.2020.06.013

Abstract

Abstract: PURPOSE: The characteristics of Sjögren's syndrome (SS) with misdiagnosis of salivary gland masses were analyzed to provide reference for clinical diagnosis. METHODS: This study retrospectively analyzed the clinical data of 45 patients who underwent parotid / submandibular gland tumor resection and had a final pathological diagnosis of benign lymphoepithelial disease, and compared with salivary gland tumor diseases. Microsoft excel was used to build a database and perform statistical analysis. RESULTS: All involvement 45 patients were female, 24.4% of the patients had bilateral salivary glands, a small number of patients complained dry mouth (11.1%), dry eyes (4.4%), easy fatigue (6.7%), joint pain (22.2%) and other clinical symptoms, nearly half of the patients had moderate mass texture (55.6%) and low mobility (53.3%). Among 35 patients who received CT examination, 13 (37.1%) reported the possibility of autoimmune diseases; 15 (53.3%) received B ultrasound examination, and 13 (76.9%) received MRI examination. The reports of 8 (53.3%) and 10 (76.9%) patients respectively suggested the possibility of autoimmune diseases. CONCLUSIONS: For middle-aged women with salivary gland tumor as the chief complaint, especially those with bilateral involvement of the tumor, SS should be excluded before surgery. B-ultrasound and MRI can be used as additional clinical routine examinations in addition to CT for the initial diagnosis of salivary gland tumor.

Key words: Sjögren's syndrome, Parotid, Submandibular gland, Parotidectomy, Submandibular gland resection

CLC Number:

R781.7

HUANG Jian-hu, YIN Xue-lai, SHI Huan, HU Yong-jie. Review and analysis of misdiagnosis of Sjögren's syndrome with salivary gland mass[J]. China Journal of Oral and Maxillofacial Surgery, 2020, 18(6): 535-538.

References

[1] Fox RI.Sjögren's syndrome[J]. Lancet, 2005, 366(9482): 321-331.
[2] Bowman SJ.Primary Sjögren's syndrome[J]. Lupus, 2018, 27(1_suppl): 32-35.
[3] Marshall LL, Stevens GA.Management of primary Sjögren's syndrome[J]. Consult Pharm, 2018, 33(12): 691-701.
[4] Zheng L, Yu C, Yang C, et al.The serological profiles of subgroup of primary Sjögren's syndrome correlation with the clinical features of parotid glands[J]. J Craniomaxillofac Surg, 2014, 42(7): 1260-1264.
[5] Moeller K, Esser D, Boeger D, et al.Parotidectomy and submandibulectomy for benign diseases in Thuringia, Germany: a population-based study on epidemiology and outcome[J]. Eur Arch Otorhinolaryngol, 2013, 270(3): 1149-1155.
[6] Badlani J, Gupta R, Balasubramanian D, et al.Primary salivary gland malignancies: a review of clinicopathological evolution, molecular mechanisms and management[J]. ANZ J Surg, 2018, 88(3): 152-157.
[7] Sood S, McGurk M, Vaz F. Management of salivary gland tumours: United Kingdom National Multidisciplinary Guidelines[J]. J Laryngol Otol, 2016, 130(S2): S142-S149.
[8] Yu G, Peng X.Conservative and functional surgery in the treatment of salivary gland tumours[J]. Int J Oral Sci, 2019, 11(3): 22.
[9] Bozinovic MT, Katic V, Krasic D, et al.Clinical, histopathological and immunohistological study of lymphoid disorders in the parotid gland of patients with Sjögren's syndrome[J]. Vojnosanit Pregl, 2009, 66(12): 955-960.
[10] 郑凌艳, 俞创奇, 胡北平, 等. 联合免疫抑制疗法治疗类肿瘤型舍格伦综合征的疗效研究[J]. 口腔医学研究, 2004, 20(2): 177-179.
[11] Lee KA, Lee SH, Kim HR. Diagnostic and predictive evaluation using salivary gland ultrasonography in primary Sjögren's syndrome [J]. Clin Exp Rheumatol, 2018, 36 Suppl 112(3): 165-172.
[12] Kojima I, Sakamoto M, Iikubo M, et al.Diagnostic performance of MR imaging of three major salivary glands for Sjögren's syndrome[J]. Oral Dis, 2017, 23(1): 84-90.
[13] Ding C, Xing X, Guo Q et al. Diffusion-weighted MRI findings in Sjögren's syndrome: a preliminary study[J]. Acta Radiol, 2016, 57(6): 691-700.
[14] Mossel E, Delli K, van Nimwegen JF, et al. Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sjögren's syndrome[J]. Ann Rheum Dis, 2017, 76(11):1883-1889.
[15] Zenone T.Parotid gland non-Hodgkin lymphoma in primary Sjögren syndrome[J]. Rheumatol Int, 2012, 32(5): 1387-1390.
[16] Madero-Visbal R, Milas Z.The role of parotidectomy in Sjögren's syndrome[J]. Oral Maxillofac Surg Clin North Am, 2014, 26(1): 83-90.
[17] Burke C, Thomas R, Inglis C et al. Ultrasound-guided core biopsy in the diagnosis of lymphoma of the head and neck. A 9 year experience[J]. Br J Radiol, 2011, 84(1004): 727-732.
[18] Tsukamoto M, Suzuki K, Takeuchi T.Ten-year observation of patients with primary Sjögren's syndrome: Initial presenting characteristics and the associated outcomes[J]. Int J Rheum Dis, 2019, 22(5): 929-933.